Alpine Associates Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Alpine Associates Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-627,500	Closed	-$15M	–	67
2021 Q1	$15M	Buy	+627,500	New	+$11.7M	0.41%	43

Alpine Associates Management's GNMK Position: Q2 2021 in Review

Alpine Associates Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 627,500 shares — an estimated $15M sold.

Alpine Associates Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $15M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Alpine Associates Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Alpine Associates Management sold 627,500 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $15M.
Alpine Associates Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Alpine Associates Management's GenMark Diagnostics, Inc position peaked at $15M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Alpine Associates Management's 13F filing for Q2 2021, filed 11 Aug 2021.